| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | EVP, R&D
2 companies
Leonard John M is a President And CEO at Intellia Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $17.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| Jun 3, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| Dec 20, 2019 | IQV Iqvia Holdings Inc. | Director | Sale+OE | 20,200 | $153.00 | $3,090,600.00 | -43.2% | |
| May 14, 2018 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sell | 8,400 | $24.00 | $201,600.00 | -100% |